Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

Vaxart sent this email to their subscribers on September 30, 2024.

September 30, 2024 4:12 PM EDT

Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

View this release →

Or click here to view all releases.

Text-only version of this email

Vaxart, Inc. September 30, 2024 4:12 PM EDT Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate View this release → Or click here to view all releases.

Show all

The Latest Emails Sent By Vaxart

Weekly Summary Alert for Vaxart, Inc.

Weekly Summary Alert for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 8-K for Vaxart, Inc.

New Form 8-K for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.

Stock Quote Notification for Vaxart, Inc.